- Home
- Unlocking the immune system
Unlocking the immune system
The immune system is meant to defend the body against diseases—but for millions of people around the world, that’s not always the case. That’s why we are committed to advancing scientific and technological solutions that not only provide treatment against diseases but offer the possibility to recalibrate the body’s ability to fend for itself. At Johnson & Johnson, we are unlocking the immune system to reimagine living and restore living to life.
Innovating in Health&Care
What is IL-23?
This pro-inflammatory protein is the target of potential Johnson & Johnson medications that could help treat immune-mediated diseases such as psoriasis, inflammatory bowel disease and rheumatoid arthritis.
5 things we now know about eczema (a.k.a., atopic dermatitis)
The most common inflammatory skin disease causes scaly patches, blisters and severe itching, but it’s far more than just a cosmetic concern. Learn why Johnson & Johnson is focused on helping the millions living with this painful condition.
Johnson & Johnson’s decades-long quest to develop effective treatments for IBD
Inflammatory bowel disease doesn’t have a cure—yet. But the recent FDA approval of a promising medication is the latest in a long line of treatments from Johnson & Johnson that are helping patients with IBD.
Juvenile myasthenia gravis: Inside one adolescent’s journey
The condition is typically diagnosed in adults, but research suggests an uptick in adolescent patients. Learn more about the rare autoantibody disease, how one teen is managing it and why Johnson & Johnson is working to improve treatment options for patients of all ages.
What is wAIHA?
Warm autoimmune hemolytic anemia (wAIHA) causes fatigue so profound, it can limit the lives of people who have the condition. Learn more about this rare disease and a potential targeted treatment developed by Johnson & Johnson that’s currently in clinical trials.
Quiz: How much do you know about psoriasis?
The chronic skin condition causes itchy and scaly patches, but it’s much more than simply a cosmetic concern. Take this quiz to test your psoriasis IQ—and learn why Johnson & Johnson is working on new and more effective treatments for this common immune-mediated disease.
The future of immunology
Learn about the advances Johnson & Johnson is making to potentially help treat the millions of people living with conditions in which the immune system mistakenly damages healthy cells in the body.
What is inflammation?
When inflammation lingers, it can lead to inflammatory bowel disease, psoriasis and rheumatoid arthritis, among other immune-mediated inflammatory diseases. Learn how Johnson & Johnson is innovating to help bring relief to those living with chronic inflammatory conditions.
“Patients are the center of everything": Meet the scientist dedicated to developing IBD treatments
Her natural curiosity, determination and fascination with science inspired Esi Lamousé, M.D., Ph.D., to pursue a career that’s helped bring innovative therapies for inflammatory bowel disease to patients in need around the world.
What is a rheumatic disease?
More than 200 conditions are classified as rheumatic diseases, including rheumatoid arthritis, lupus and Sjögren’s disease. Here’s what a doctor wants you to know about the different types, symptoms and risk factors—and how Johnson & Johnson is innovating new treatments.
More from Johnson & Johnson
What is lupus?
Up to 5 million people worldwide live with this complex autoimmune condition, which is more prevalent in women and has a greater disease severity in Latin Americans and patients of African ancestry. Learn how Johnson & Johnson is working to innovate treatments for autoimmune diseases.
What you need to know about Johnson & Johnson’s fourth-quarter and full-year 2025 earnings report
Check out this infographic breakdown of the company’s full-year performance, with highlights from its Innovative Medicine and MedTech businesses.
What is cardiac ablation?
Learn how Johnson & Johnson is innovating to help treat the millions of people who are living with atrial fibrillation and other conditions that cause an irregular heartbeat.